Sintx Technologies, Inc. SINT
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-02-11
Sintx Technologies, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.3% | 71.9% | 70.2% | 83.0% | 25.9% | 20.0% | 20.0% | 41.1% | 43.4% | 75.2% |
| Operating margin | -1053.1% | -486.6% | -508.5% | -726.1% | -1752.5% | -1431.6% | -957.0% | -13806.3% | -66.7% | -75.8% |
| Net margin | -1018.1% | -381.8% | -314.4% | -771.2% | -1536.1% | -1183.3% | -696.2% | -9107.4% | -83.1% | -97.0% |
| FCF margin | -860.1% | -323.2% | -557.5% | -747.5% | -2288.9% | -1594.6% | -955.3% | -9851.6% | -63.5% | -51.5% |
| Return on assets | -109.0% | -117.1% | -53.8% | -76.3% | -42.6% | -23.1% | -52.4% | -75.1% | -63.7% | -56.2% |
| Return on equity | -353.8% | -283.1% | -94.2% | -211.1% | -54.1% | -27.2% | -92.2% | -103.0% | -171.4% | -131.4% |
| Debt / equity | — | — | — | 0.06× | — | 0.01× | 0.00× | — | 0.54× | 1.06× |
| Current ratio | 1.51 | 2.28 | 1.90 | 0.89 | 5.47 | 9.58 | 1.97 | 2.95 | 0.44 | 1.14 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.